Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-24 · accession 0001735276-25-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-25 | 2025-03-24 | ALNY | PYOTT DAVID E I | Dir | M - OptEx | $88.95 | +7,440 | 7,576 | +5,471% | +$661.8K |
| D | 2025-03-25 | 2025-03-24 | ALNY | PYOTT DAVID E I | Dir | S - Sale+OE | $299.00 | -7,440 | 136 | -98% | -$2.22M |
| D | 2025-03-25 | 2025-03-24 | ALNY | PYOTT DAVID E I | Dir | M - OptEx | $0.00 | -7,440 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-24 | M | A | 7,440 | $88.95 | 7,576 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-24 | S | D | 7,440 | $299.00 | 136 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-03-24 | M | D | 7,440 | $0.00 | 0 | D | $88.95 · — to 2025-12-18 | 7,440 Common Stock | (F3) This stock option was fully vested and exercisable as of December 18, 2016. |